Skip to main content
. Author manuscript; available in PMC: 2014 Jul 16.
Published in final edited form as: Biol Blood Marrow Transplant. 2008 Jul;14(7):783–789. doi: 10.1016/j.bbmt.2008.04.006

Figure 3.

Figure 3

Kaplan-Meier estimates of progression free survival (black and grey curves depict infliximab treated and control groups respectively) Log-rank p-value = 0.50.